Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).

Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...

Medtronic announced it has entered into an exclusive United States distribution agreement with Japan-based Future Medical Design C ...

Trends point to more and more PCIs being performed via the wrist, but the US still trails behind other countries.

Radical Catheter Technologies ™, a pioneering medical device company and a NeuroTechnology Investors (NTI) portfolio company focused on advancing the next ...

Dr. Justin Dunn, who oversees the heart disease program, says patients can now receive the same level of care as UH Cleveland ...

The Impella device (Impella, Abiomed, Danvers, MA) is a percutaneous transvalvular microaxial flow pump that is currently used for (1) cardiogenic shock, (2) left ventricular unloading (combination of ...

Here, we present an instrumented catheter equipped with a hemocompatible electrochemical sensor to continuously monitor one of the key parameters- glucose, lactate, and pH, directly in blood.